HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Net Cash Provided by Financing Activities

Last Annual Value

16.59M

3-Year CAGR

262%

5-Year CAGR

93%

10-Year CAGR

28%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Net Cash Provided by Financing Activities

BEAT · NASDAQ
CompanyNet Cash Provided by Financing Activities
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
16.59M
-12.8%0.2%27.8% 
30.43M
N/A-0.4%N/A
43.48M
-4.0%132.3%N/A
26.29M
30.4%6.5%5.8%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
25.75M
-17.7%113.2%N/A
903.00K
-65.2%-27.5%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
244.02K
N/A-58.9%-30.0%
23.28M
55.4%-18.2%N/A
14.72B
N/A212.7%N/A
6.03M
-53.1%-44.0%N/A
12.78M
64.4%33.2%N/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47